Alira Health Joins EMIG to Advance Market Access in the UK
We are pleased to announce that Alira Health has joined the Ethical Medicines Industry Group (EMIG), a multi-stakeholder network and trade association that represents the interests of life sciences companies in the UK.
EMIG represents its over 300 industry members and associate members to government, the NHS, regulatory bodies, and academic research organisations in order to ensure that patients are able to access a wide range of innovative medicines. And EMIG encompasses the breadth of the health and medicines ecosystem in the UK, which makes it a vital platform for greater knowledge and ideas exchange. Alira Health’s access to this platform strengthens our ability to serve our clients in the UK while advancing our global market access solutions.
“The growth and sustainability of the UK health ecosystem is critical to providing patients with access to quality care, and that ecosystem growth is central to EMIG’s mission. At Alira Health, we put patients at the centre of everything we do. Working with EMIG aligns us with a valuable source of expertise and knowledge that will benefit our clients as we work together to get much-needed products to patients in the UK market,” said Richard Charter, Vice President MedTech Market Access – Europe & Asia Pacific.
Membership in EMIG will enable Alira Health to stay current on new UK developments and those on the horizon and to better prepare our clients for challenges and opportunities ahead in the UK market.
This news follows on the heels of Alira Health’s partnership with leading UK market access specialist consultancy Policy Matters, as we further align with resources for the complex and challenging UK market.